Pay in 4 interest-free payments of $5.44 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Step 5: Push the plunger to release the 5 mL of bacteriostatic water into the Tri-Mix injectable vial of powder
;Resize=(1280,712))
Across the literature the compound appears under several alternate identifiers: 5-Amino-1MQ
Retatrutide is an investigational peptide drug developed by Eli Lilly that acts as a triple agonist, simultaneously targeting three hormone receptors: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors
(Maywood) 232 , 12661274 (2007)
US$ 24.51
US$ 29.88
US$ 27.47
US$ 21.52
